Abstract:Abstract Objectives Liver hepatocellular carcinoma (LIHC) is the most common type of primary liver cancer and originates from hepatocytes, the main functional cells of the liver. It is a serious and aggressive cancer with a generally poor prognosis, especially when diagnosed at advanced stages. Reactive oxygen species (ROS) have been detected in LIHC and are involved in carcinogenesis and tumor progression. Here, a comprehensive analysis was performed to evaluate the effects of ROS-related genes on the prognosis of LIHC. Methods Using bioinformatical tools including Gene Expression Profiling Interactive Analysis (GEPIA2) and Q-omics, a comprehensive analysis was performed to evaluate the effects of ROS-related genes, including superoxide dismutases (SODs), glutathione peroxidases (GPXs), peroxiredoxins (PRDXs) and catalase (CAT) on the prognosis of LIHC using The Cancer Genome Atlas (TCGA) dataset and identified the most appropriate candidate genes. Then we further explored their effects on LIHC cell proliferation and drug selection for LIHC treatment. Results We found that CAT expression was significantly downregulated in late stage’s LIHC tissues compared to normal liver or early stage’s LIHC tissues, and high CAT expression was correlated with a favorable survival prognosis in LIHC. The expression of the CAT gene was associated with an inhibition of the “cell cycle” pathway. HepG2 and Hep3B cells’ growth was increased with a decrease in CAT expression by silencing its mRNA. As silencing of CAT in HepG2 and Hep3B cells, and its association with an increase in the expression of PLK1, CCNB1, CDC20, and PTTG1. A comparative 426 drug response in LIHC cells with different CAT expression, SU11274, a Met inhibitor, could serve as a therapeutic option when CAT levels are low in LIHC cells. Conclusions Our findings revealed that Met inhibitors could potentially control tumor progression and be used as a therapeutic option against LIHC with low CAT.

Expression and purification and of human hydrogen peroxidase in E.coli and identification of its biological activity

The Expression, Purification and Activity Analysis of Francisella Tularensis Citrulline Ureidase in Escherichia Coli

High-level expression and purification of recombinant human catalase in Pichia pastoris.

Purification, Cloning, Expression, and Biochemical Characterization of a Monofunctional Catalase, KatP, from Pigmentiphaga Sp. DL-8.

Recombination and Expression of Micrococcus luteus Catalase in E.coli

High Expression, Purification and Bioactivity of Prephenate Dehydrogenase Domain in E. Coli T-protein

High Efficient Expression and Purification of the Escherichia Coli T-protein

Identification of Cathepsin B As a Novel Target of Hypoxia-Inducible Factor-1-alpha in HepG2 Cells.

Catalase expression is an independent prognostic marker in liver hepatocellular carcinoma

Expression and identification of human ubiquitin-conjugating enzyme UBE2C/UbcH10 in E.coli

Expression of the Cytolysin Gene from Vibrio Vulnificus in E.coli and Identification of Its Hemolytic Activity

Molecular cloning, characterization, and expression level analysis of a marine teleost homolog of catalase from big belly seahorse (Hippocampus abdominalis)

Expression and Purification of Recombinant Cathepsin B

[Construction and expression of recombinant adenovirus containing human catalase gene in vitro].

Expression and Preparation of Antiserum of Human KCTD10 and Its Expression Profile in the Cell Lines

Construction of Eukaryotic Expression Vector of Heme Oxygenase-1 and Its Expression in Rat Peritoneal Mesothelial Cells

Expression,purification and preparation of monoclonal antibody of HCA518 protein

Expression of Hirulog 18in E.coli and the Test of its Biological Activity

Prokaryotic Expression,purification and Identification of GST-human S100A9 Fusion Protein

Preparation of Recombinant Its Biological Hybrid Human SOD2/3 and Activity Assay

High Expression of A Cdna Coding for Human Lymphotoxin Alpha Derivative in E-Coli and Purification of Its Protein Product